KPV 10mg

Original price was: $49.00.Current price is: $41.65.

Batch Certification
≥99%HPLC Purity
Third-party tested · Batch-matched COA
Specifications
CAS Number: 67727-97-3
Form: Lyophilized Powder
Quantity: 10mg per vial
Purity: ≥99% (HPLC verified)
Molecular Formula: C₁₆H₃₀N₄O₄
Molecular Weight: 342.44 g/mol
Storage: −20°C recommended
Stability: 24+ months lyophilized
Research Category: Research Compounds
Use: Not for human or animal use. Research laboratory use only.

Synthetic tripeptide supplied for biochemical, cellular signaling, and inflammatory pathway research models.

Buy 1 - 4 pieces
$41.65
Buy 5 - 8 pieces and save 10%
$41.65
$37.49
Buy 9+ pieces and save 20%
$41.65
$33.32
-
+

All major credit cards accepted

Product Overview

KPV (Lys-Pro-Val) is a synthetic tripeptide composed of the amino acids lysine–proline–valine. It corresponds to a short peptide sequence associated with α-melanocyte-stimulating hormone (α-MSH), and its compact three-residue structure makes it a defined, reproducible reagent for laboratory research. In research settings, KPV is studied primarily in the context of inflammatory signaling, immune-response pathways, and peptide-mediated cellular activity. Material supplied under this listing is characterized for identity and purity and is intended solely as a research reagent for controlled in vitro and preclinical laboratory investigation.

Not for human or animal use. Research laboratory use only.

All compounds referenced are supplied for laboratory and research applications only and are not for human consumption.

KPV (Lys-Pro-Val) is investigated in laboratory research as the C-terminal tripeptide sequence of α-melanocyte-stimulating hormone (α-MSH). Early experimental work identified this short sequence as an important contributor to the anti-inflammatory activity associated with α-MSH, supporting its use as a defined peptide reagent in inflammation and immunomodulation research.¹ Reviews of the melanocortin literature similarly describe KPV as retaining substantial anti-inflammatory activity despite lacking the full α-MSH sequence required for conventional melanocortin-receptor binding, while noting that its precise signaling mechanisms remain incompletely defined.²

In cell-based studies, KPV has been investigated in inflammatory signaling models, including experiments examining TNF-α-stimulated NF-κB activation in human keratinocytes.³ Separate macrophage studies have evaluated KPV and related α-MSH tripeptides in LPS/IFN-γ-stimulated nitric-oxide production, with findings suggesting activity through mechanisms distinct from classical melanocortin-receptor signaling.⁴

KPV has also been studied extensively in experimental intestinal-inflammation models. Research using intestinal epithelial and immune cells identified KPV uptake through the peptide transporter PepT1 and examined downstream NF-κB signaling, cytokine expression, and inflammatory responses; the same study evaluated KPV in DSS- and TNBS-induced mouse colitis models.⁵ Subsequent preclinical research has investigated KPV using colon-targeted delivery systems and additional animal models of intestinal inflammation.⁶

Across this body of work, KPV is examined primarily in the context of inflammatory signaling, immune-response modulation, epithelial biology, and peptide-transport mechanisms rather than any established physiological or clinical endpoint. Much of the evidence remains derived from cell culture and animal models, and the molecular mechanisms attributed to KPV are not fully resolved. Collectively, the peer-reviewed literature positions KPV as an experimental research reagent for investigating α-MSH-associated signaling and inflammatory pathways under controlled laboratory conditions.

Not for human or animal use. Research laboratory use only.

References

  1. Hiltz ME, Lipton JM. Antiinflammatory activity of a COOH-terminal fragment of the neuropeptide alpha-MSH. FASEB J. 1989. PMID: 2550304. PubMed
  2. Brzoska T, et al. Terminal signal: anti-inflammatory effects of α-melanocyte-stimulating hormone related peptides beyond the pharmacophore. Adv Exp Med Biol. 2010. PMID: 21222263. PubMed
  3. Moustafa M, et al. Inhibition of tumor necrosis factor-alpha stimulated NFkappaB/p65 in human keratinocytes by alpha-melanocyte stimulating hormone and adrenocorticotropic hormone peptides. J Invest Dermatol. 2002. PMID: 12485424. PubMed
  4. Getting SJ, et al. Effects of alpha-melanotropin C-terminal tripeptide analogues on macrophage NO production. PMID: 12895656. PubMed
  5. Dalmasso G, et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008. PMID: 18061177. PubMed
  6. Laroui H, et al. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model. Gastroenterology. 2010. PMID: 19909746. PubMed
For laboratory research use only. Not for human or veterinary consumption.

Built for Precision. Designed for Research.

A professional platform for accessing research compounds with clarity, consistency, and research-first standards.

Transparent & Trusted

From sourcing to fulfillment, every step of our process is structured around clarity, consistency, and professional research standards.

Structured Research Access

Our platform is built to support efficient research workflows with organized categories, standardized product presentation, and simple reordering.

Research-Focused Standards

Every product is presented in formats designed for stability, professional handling, and alignment with laboratory environments.

4.8 Stars

Why Researchers Trust The Precision Research Peptide

Bestseller Compounds

Committed to Research Integrity

Our approach prioritizes clarity, structure, and transparency. Each compound is presented with research-focused documentation, neutral communication, and consistent labeling to support scientific workflows.

We believe long-term trust is built through precision, not promotion.